Conjugation of para-nitrophenol by isolated perfused fetal sheep liver

Drug Metabolism and Disposition

Volumn 24, Issue 12, 1996, Pages 1378-1384

  Ring, John A ^a   Ghabrial, Hany ^a   Ching, Michael S ^a   Shulkes, Arthur ^a   Smallwood, Richard A ^a   Morgan, Denis J ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

4 NITROPHENOL;

ANIMAL TISSUE; ARTICLE; BILE; CONJUGATION; DRUG CLEARANCE; DRUG DISPOSITION; DRUG GLUCURONIDATION; DRUG METABOLISM; DRUG SULFATION; FEMALE; FETUS; FETUS LIVER; LIVER METABOLISM; MALE; MICHAELIS CONSTANT; NONHUMAN; PRIORITY JOURNAL; SHEEP;

ANIMALS; AREA UNDER CURVE; BLOOD PRESSURE; FEMALE; GLUCURONATES; HALF-LIFE; LIVER; MALE; NITROPHENOLS; PERFUSION; PREGNANCY; REGRESSION ANALYSIS; SHEEP; SULFATES;

ANIMALIA; OVIS ARIES;

EID: 0030479952     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. B. Krauer and P. Dayer: Fetal drug metabolism and its possible clinical implications. Clin. Pharmacokinet. 21, 70-80 (1991).
2. M. W. H. Coughtrie, K. J. Bamforth, S. Sharp, A. L. Jones, E. B. Borthwick, E. V. Barker, R. C. Roberts, R. Hume, and B. Burchell: Sulfation of endogenous compounds and xenobiotics: interactions and function in health and disease. Chem. Biol. Interact. 92, 247-256 (1994).
3. J. O. Miners and P. I. Mackenzie: Drug glucuronidation in humans. Phamacol. Ther 51, 347-369 (1991).
4. J. L. Raucy and S. J. Carpenter: The expression of xenobiotic-metabolizing cytochromes P450 in fetal tissues. J. Pharmacol. Toxicol. Methods 29, 121-128 (1993).
5. R. A. deLemos and T. J. Kuehl: Animal models for evaluation of drugs for use in the mature and immature newborn. Pediatrics 79, 275-280 (1987).
6. 14C]-sodium taurocholate by the isolated perfused fetal sheep liver. Biochem. Pharmacol. 48, 667-674 (1994).
7. J. A. Ring, H. Ghabrial, M. S. Ching, A. Shulkes, R. A. Smallwood, and D. J. Morgan: Fetal hepatic propranolol metabolism: studies in the isolated perfused fetal sheep liver. Drug Metab. Dispos. 23, 190-196 (1995).
8. S. H. L. Chiu: The use of in vitro metabolism studies in the understanding of new drugs. J. Pharmacol. Toxicol. Methods 29, 77-83 (1993).
9. M. Gibaldi and D. Perrier: "Pharmacokinetics." Marcel Dekker, New York, 1982.
10. R. D. Purves: Anomalous parameter estimates in the one compartment model with first order absorption. J. Pharm. Pharmacol. 45, 934-946 (1993).
11. M. C. Mitchell, S. D. Hall, S. Schenker, and R. A. Branch: Impaired hepatic elimination of paranitrophenol and its metabolites in the rat following chronic ethanol pretreatment. Alcohol Clin. Exp. Res. 13, 264-270 (1989).
12. G. R. Wilkinson: Clearance approaches in pharmacology. Pharmacol. Rev. 39, 1-47 (1987).
13. K. S. Pang, M. Rowland, and T. N. Tozer: In vivo evaluation of Michaelis-Menten constants of hepatic drug-eliminating systems. Drug Metab. Dispos. 6, 197-200 (1978).
14. J. G. Wagner, G. J. Szpunar, and J. J. Ferry: Michaelis-Menten elimination kinetics: areas under curves, steady-state concentrations, and clearances for compartment models with different types of input. Biopharm. Drug Dispos. 6, 177-200 (1985).
15. W. J. Jusko: Pharmacokinetics of capacity-limited systems. J. Clin. Pharmacol. 29, 488-493 (1989).
16. M. E. Morris and S. B. Hansel: High-performance liquid chromatographic analysis of p-nitrophenol and its conjugates in biological samples. J. Chromatogr. 532, 285-293 (1990).
17. G. W. Mihaly, D. J. Morgan, R. A. Smallwood, and K. J. Hardy: The developing liver: the steady-state disposition of propranolol in pregnant sheep. Hepatology 2, 344-349 (1982).
18. H. Ghabrial, N. Bichara, R. A. Smallwood, and D. J. Morgan: Effect of plasma oestradiol concentration on 4-nitrophenol glucuronidation in the pregnant rat. Pharm. Sci. 1, 27-30 (1994).
19. W. Tassaneeyakul, M. E. Veronese, D. J. Birkett, F. J. Gonzalez, and J. O. Miners: Validation of 4-nitrophenol as an in vitro substrate probe for human liver CYP2E1 using cDNA expression and microsomal kinetic techniques. Biochem. Pharmacol. 46, 1975-1981 (1993).
20. G. J. Mulder: Kinetics of sulfation in the rat in vivo and in the perfused rat liver. Fed. Proc. 45, 2229-2234 (1986).
21. M. E. Morris, V. Yuen, B. K. Tang, and S. Pang: Competing pathways in drug metabolism. 1. Effect of input concentration on the conjugation of gentisamide in the once-through in situ perfused rat liver preparation. J. Pharmacol. Exp. Ther. 245, 614-624 (1988).
22. R. Gebhart: Metabolic zonation of the liver: regulation and implications for liver function. Pharmacol. Ther. 53, 275-354 (1992).
23. J. Watanabe, Y. Asaka, and S. Kanamura: Postnatal development and sublobular distribution of cytochrome P-450 in rat liver: a microphotometric study. J. Histochem. Cytochem. 41, 397-400 (1993).
24. D. Ratanasavanh, P. Beaune, F. Morel, J. P. Flinois, F. P. Guengerich, and A. Guillouzo: Intralobular distribution and quantitation of cytochrome P-450 enzymes in human liver as a function of age. Hepatology 13, 1142-1151 (1991).
25. L. H. Wang, A. M. Rudolph, and L. Z. Benet: Comparative study of acetaminophen disposition in sheep at three developmental stages: the fetal, neonatal and adult periods. Dev. Pharmacol. Ther. 14, 161-179 (1990).
26. L. H. Wang, A. M. Rudolph, and L. Z. Benet: Pharmacokinetic studies of the disposition of acetaminophen in the sheep maternal-placental-fetal unit. J. Pharmacol. Exp. Ther. 238, 198-205 (1986).
27. B. H. Dvorchik, G. Woodward, D. S. Sitar, and W. A. Tweed: Hydroxylation and glucuronidation of various xenobiotics by hepatic microsomes from the fetal lamb, pregnant ewe and human fetus. Dev. Pharmacol. Ther. 9, 282-289 (1986).
28. R. A. Branch, R. Cotham, R. Johnson, J. Porter, P. V. Desmond, and S. Schenker: Periportal localization of lorazepam glucuronidation in the isolated perfused rat liver. J. Lab. Clin. Med. 102, 805-812 (1983).
29. L. H. Wang, D. Zakim, A. M. Rudolph, and L. Z. Benet: Developmental alterations in hepatic UDP-glucuronosyltransferase: a comparison of the kinetic properties of enzymes from adult sheep and fetal lambs. Biochem. Pharmacol. 35, 3065-3070 (1986).
30. M. W. H. Coughtrie, B. Burchell, J. E. A. Leakey, and R. Hume: The inadequacy of perinatal glucuronidation: immunoblot analysis of the developmental expression of individual UDP-glucuronyltransferase isoenzymes in rat and human liver microsomes. Mol. Pharmacol. 34, 729-735 (1988).
31. D. P. Chauhan, M. S. Miller, I. S. Owens, and L. M. Anderson: Gene expression, ontogeny and transplacental induction of hepatic UDP-glucuronosyltransferase activity in mice. Dev. Pharmacol. Ther. 16, 139-149 (1991).
32. D. M. Otterness and R. Weinshilboum: Human dehydroepiandrosterone sulfotransferase: molecular cloning of cDNA and genomic DNA. Chem. Biol. Interact 92, 145-159 (1994).
33. C. N. Falany and T. W. Wilborn: Biochemistry of cytosolic sulfotransferases involved in bioactivation. Adv. Pharmacol. 27, 301-329 (1994).
34. G. M. Pacifici, M. Franchi, C. Colizzi, L. Giuliani, and A. Rane: Sulfotransferase in humans: development and tissue distribution. Pharmacology 36, 411-419 (1988).
35. M. Cappiello, M. Franchi, A. Rane, and G. M. Pacifici: Sulphotransferase and its substrate adenosine-3′-phosphate-5′-phosphosulphate in human fetal liver and placenta. Dev. Pharmacol. Ther. 14, 62-65 (1990).
36. R. A. Gilissen, R. Hume, J. H. Meerman, and M. W. Coughtrie: Sulphation of N-hydroxy-4-aminobiphenyl and N-hydroxy-4-acetylaminobiphenyl by human foetal and neonatal Sulphotransferase. Biochem. Pharmacol. 48, 837-840 (1994).
37. M. Cappiello, L. Giuliani, A. Rane, and G. M. Pacifici: Dopamine sulphotransferase is better developed than p-nitrophenol sulphotransferase in the human fetus. Dev. Pharmacol. Ther. 16, 83-88 (1991).
38. G. M. Pacifici, M. Franchi, L. Giuliani, and A. Rane: Development of the glucuronyltransferase and sulphotransferase towards 2-naphthol in human fetus. Dev. Pharmacol. Ther. 14, 108-114 (1990).
39. A. L. Jones, R. Hume, K. J. Bamforth, and M. W. Coughtrie: Estrogen and phenol sulfotransferase activities in human fetal lung. Early Hum. Dev. 28, 65-77 (1992).
40. G. M. Pacifici, M. Kubrich, L. Giuliani, V. M. de Vries, and A. Rane: Sulphation and glucuronidation of ritodrine in human foetal and adult tissues. Eur. J. Clin. Pharmacol. 44, 259-264 (1993).
41. M. R. Juchau, S. T. Chao, and C. J. Omiecinski: Drug metabolism by the human fetus. Clin. Pharmacokinet. 5, 320-339 (1980).